Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 101, Issue 7, 2007, Pages 1439-1446

  Karadag, Fisun ^a   Ozcan, Hatice ^a   Karul, Aslihan B ^b   Yilmaz, Mustafa ^b   Cildag, Orhan ^a  

^a School of Medicine   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Interleukin 6; Non thyroidal illness syndrome; Thyroid hormones; Tumor necrosis factor alpha

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LIOTHYRONINE; STEROID; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; FOLLOW UP; FREE THYROXINE INDEX; HORMONE DETERMINATION; HUMAN; HYPOXEMIA; LIOTHYRONINE BLOOD LEVEL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NON THYROIDAL ILLNESS SYNDROME; PRIORITY JOURNAL; REFERENCE VALUE; REMISSION; SYSTEMIC DISEASE; THYROID DISEASE; THYROID FUNCTION TEST; THYROXINE BLOOD LEVEL;

ACUTE DISEASE; AGED; CARBON DIOXIDE; EUTHYROID SICK SYNDROMES; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-6; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THYROID FUNCTION TESTS; THYROID HORMONES; TUMOR NECROSIS FACTOR-ALPHA; VITAL CAPACITY;

EID: 34249682143     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.01.016     Document Type: Article

References (33)

1. Vernooy J.H., Kucukaycan M., Jacobs J.A., Chavannes N.H., Buurman W.A., Dentener M.A., et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 1218-1224
2. Wouters E.F., Creutzberg E.C., and Schols A.M. Systemic effects in COPD. Chest 121 Suppl. (2002) 127s-130s
3. Dimopoulou I., İlias I., Mastorakos G., Mantzos E., Roussos C., and Koutras D.A. Effects of severity chronic obstructive pulmonary disease on thyroid function. Metabolism 50 12 (2001) 1397-1401
4. Chopra I.J. Euthyroid sick syndrome: is it a misnomer?. J Clin Endocrinol Metab 82 2 (1996) 329-334
5. Boelen A., Kwakkel I., Schiphorst M.P., Mentrun B., Baur A., Kochric J., et al. IL-18, a proinflammatory cytokine, contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis. Eur J Endocrinol 151 (2004) 497-502
6. Davies P.H., Black E.G., Sheppard M.C., and Franklyn J.A. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clin Endocrinol 44 (1996) 199-205
7. Slag M.F., Morley J.E., Elson M.K., Crowson T.W., Nettle F.Q., and Shafer R.B. Hypothyroxinemia in critically ill patients as a predictor of high mortality. J Am Med Assoc 245 (1981) 43-45
8. Hamilton M.A. Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann Thorac Surg 56 Suppl 1 (1993) S48-S52
9. Rasmussen A.K. Cytokine actions on the thyroid gland. Dan Med Bull 47 2 (2000) 94-114
10. Stouthard J.M.L., van der Poll T., Endert E., Bakker P.J.M., Veenhof C.H.N., Sauerwein H.P., et al. Effects of acute and chronic IL-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 79 5 (1994) 1342-1346
11. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD). Global strategy fort he diagnosis, management and prevention of chronic obstructive lung disease (Updated 2005). [Accessed 18. 08. 2005] Available from URL: http://www.goldcopd.com/ 〈http://www.goldcopd.com/〉.
12. Anthonisen N.R., Manfreda J., Warren C.P., Hershfield E.S., Harding G.K., and Nelson N.A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106 (1987) 196-204
13. WHO Expert Committee. Physical status: The use and interpretation of anthropometry. WHO technical report series no: 854. 1995, Geneva, WHO.
14. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 152 (1995) 1107-1136
15. Semple Pd'A, Beastall GH, Watson WS, Hume R. Hypotalamic-pituitary dysfunction in respiratory hypoxia. Thorax 1981; 36:605-609.
16. Gow S.M., Seth J., Beckett G.J., and Douglas G. Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease. Thorax 42 (1987) 520-525
17. Semple Pd'A, Watson WS, Beastall GH, Bethel MIF, Grant JK, Hume R. Diet absorption and hormone studies in relation to body weight in obstructive airways disease. Thorax 1979; 34: 783-788.
18. Banks W.A., and Cooper J.A. Hypoxia and hypercarbia of chronic lung disease: Minimal effects on anterior pituitary function. South Med J 83 (1990) 290-293
19. Okutan O., Kartaloglu Z., Onde M.E., Bozkanat E., and Kunter E. Pulmonary function tests and thyroid hormone concentrations in patients with chronic obstructive pulmonary disease. Med Princ Pract 13 (2004) 126-128
20. Blum C.J., Lafont C., Ducasse M., Hoff M., Labarre I., Bayard F., et al. Thyroid function tests in ageing and their relation to associated nonthyroidal disease. J Endocrinol Invest 12 (1989) 307-312
21. Karadag F., Karul A.B., Cildag O., Altun C., and Gurgey O. Determinants of BMI in patients with COPD. Respirology 9 (2004) 70-75
22. Ozawa M., Sato K., Han D.C., Kawakami M., Tsushima T., and Shizume K. Effects of tumor necrosis factor-alpha on thyroid hormone metabolism in mice. Endocrinology 123 3 (1988) 1461-1467
23. van der Poll T., Romijn J.A., Wiersinga W.M., and Sauerwein H.P. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome. J Clin Endocrinol Metab 71 (1991) 1567-1572
24. Hermus A.R., and Sweep C.G. Cytokines and the hypothalamic-pituitary-adrenal axis. J Steroid Biochem Mol Biol 37 6 (1990) 867-871
25. Hashimoto H., Igarashi N., Yachie A., Miyawaki T., and Sato T. The relationship between serum levels of IL-6 and thyroid hormone in children with acute respiratory infection. J Clin Endocrinol Metab 78 2 (1994) 288-291
26. Boelen A., Platvoet-ter Schiphorst M.C., and Wiersinga W.M. Immunoneutrolization of IL-1, TNF-α, IL-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. J Endocrinol 153 1 (1997) 115-122
27. Chopra I.J., Sakane S., and Teco G.N. A study of the serum concentration of TNF-α in thyroidal and non-thyroidal illnesses. J Clin Endocrinol Metab 72 5 (1991) 1113-1116
28. Opasich C., Pacini F., Ambrosino N., Riccardi P.G., Febo O., Ferrari R., et al. Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J 17 (1996) 1860-1866
29. Bacci V., Schussler G.C., and Kaplan T.C. The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab 54 (1982) 1229-1235
30. Feelders R.A., Swaak A.J., Romijn J.A., Eggermont A.M., Tielens E.T., Vreugdenhil G., et al. Characteristics of recovery from the euthyroid sick syndrome induced by TNF-α in cancer patients. Metabolism 48 3 (1999) 324-329
31. Becker R.A., Vaughan G.M., Ziegler M.G., Seraile L.G., Goldfarb I.W., Mansour E.H., et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 10 (1982) 870-875
32. Dulchavsky S.A., Hendrick S.R., and Dutta S. Pulmonary biophysical effects of triiodothyronine (T3) augmentation during sepsis-induced hypothyroidism. J Trauma 35 (1993) 104-109
33. Klemperer J.D., Klein I., Gomez M., Helm R.E., Ojamaa K., Thomas S.J., et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333 (1995) 1522-1527